A detailed history of Verition Fund Management LLC transactions in Taro Pharmaceutical Industries LTD stock. As of the latest transaction made, Verition Fund Management LLC holds 6,647 shares of TARO stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,647
Previous 5,622 18.23%
Holding current value
$0
Previous $234,000 20.09%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$40.97 - $43.33 $41,994 - $44,413
1,025 Added 18.23%
6,647 $281,000
Q4 2023

Feb 14, 2024

SELL
$32.77 - $42.31 $2.03 Million - $2.62 Million
-61,962 Reduced 91.68%
5,622 $234,000
Q3 2023

Nov 14, 2023

BUY
$35.46 - $40.13 $2.4 Million - $2.71 Million
67,584 New
67,584 $2.55 Million

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.